Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16305312
[patent_doc_number] => 10774090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Pyrimidine compounds and pyrimido indole compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/253751
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11867
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253751
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253751 | Pyrimidine compounds and pyrimido indole compounds and methods of use | Jan 21, 2019 | Issued |
Array
(
[id] => 17603987
[patent_doc_number] => 11332458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Method for preparing N-alkoxycarbonylpiperidine derivative, and intermediate therefor
[patent_app_type] => utility
[patent_app_number] => 16/962394
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4514
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962394 | Method for preparing N-alkoxycarbonylpiperidine derivative, and intermediate therefor | Jan 17, 2019 | Issued |
Array
(
[id] => 16898912
[patent_doc_number] => 20210177828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => TAM FAMILY KINASE /AND CSF1R KINASE INHIBITOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/733382
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733382
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733382 | TAM FAMILY KINASE /AND CSF1R KINASE INHIBITOR AND USE THEREOF | Jan 16, 2019 | Pending |
Array
(
[id] => 16626732
[patent_doc_number] => 20210045385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES
[patent_app_type] => utility
[patent_app_number] => 16/963810
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 401
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963810 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | Jan 16, 2019 | Abandoned |
Array
(
[id] => 17407124
[patent_doc_number] => 11247993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Pyridone derivative, composition and use as antiviral drug thereof
[patent_app_type] => utility
[patent_app_number] => 16/487088
[patent_app_country] => US
[patent_app_date] => 2019-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15972
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 837
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487088 | Pyridone derivative, composition and use as antiviral drug thereof | Jan 15, 2019 | Issued |
Array
(
[id] => 16060955
[patent_doc_number] => 10689409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Amino compounds for treatment of complement mediated disorders
[patent_app_type] => utility
[patent_app_number] => 16/246832
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28506
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 886
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246832 | Amino compounds for treatment of complement mediated disorders | Jan 13, 2019 | Issued |
Array
(
[id] => 16421847
[patent_doc_number] => 20200347045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => CRBN LIGANDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/961362
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 593
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961362 | CRBN ligands and uses thereof | Jan 13, 2019 | Issued |
Array
(
[id] => 16042881
[patent_doc_number] => 10683299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases
[patent_app_type] => utility
[patent_app_number] => 16/247170
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16894
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16247170
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/247170 | Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases | Jan 13, 2019 | Issued |
Array
(
[id] => 18028921
[patent_doc_number] => 11512094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Furoxan-based compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/960470
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15177
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960470
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960470 | Furoxan-based compounds and uses thereof | Jan 10, 2019 | Issued |
Array
(
[id] => 14230405
[patent_doc_number] => 20190127375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/245004
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245004
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245004 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | Jan 9, 2019 | Abandoned |
Array
(
[id] => 16711839
[patent_doc_number] => 20210078986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 (BCL9) PROTEIN-PROTEIN INTERACTION
[patent_app_type] => utility
[patent_app_number] => 16/960912
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960912 | INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 (BCL9) PROTEIN-PROTEIN INTERACTION | Jan 8, 2019 | Abandoned |
Array
(
[id] => 14273433
[patent_doc_number] => 20190134001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => FK506 DERIVATIVE MAINTAINING NERVE REGENERATION ACTIVITY WITHOUT IMMUNOSUPPRESSIVE ACTIVITY, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/242386
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16242386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/242386 | FK506 derivative maintaining nerve regeneration activity without immunosuppressive activity, and use thereof | Jan 7, 2019 | Issued |
Array
(
[id] => 14230403
[patent_doc_number] => 20190127374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/241839
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241839 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | Jan 6, 2019 | Abandoned |
Array
(
[id] => 14230401
[patent_doc_number] => 20190127373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/241837
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241837 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | Jan 6, 2019 | Abandoned |
Array
(
[id] => 16519447
[patent_doc_number] => 10870656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Methods for treatment of heart failure
[patent_app_type] => utility
[patent_app_number] => 16/240393
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 5588
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240393 | Methods for treatment of heart failure | Jan 3, 2019 | Issued |
Array
(
[id] => 18315082
[patent_doc_number] => 11629151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Method for preparing indolenaphthopyrans
[patent_app_type] => utility
[patent_app_number] => 17/416079
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8842
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416079 | Method for preparing indolenaphthopyrans | Dec 20, 2018 | Issued |
Array
(
[id] => 15512615
[patent_doc_number] => 10562883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Heterocycles capable of modulating T-cell responses, and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/229687
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 13585
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229687
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229687 | Heterocycles capable of modulating T-cell responses, and methods of using same | Dec 20, 2018 | Issued |
Array
(
[id] => 15054795
[patent_doc_number] => 10457686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => [1,2,3]triazolo[4,5-D]pyrimidine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/228546
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9507
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228546 | [1,2,3]triazolo[4,5-D]pyrimidine derivatives | Dec 19, 2018 | Issued |
Array
(
[id] => 15177967
[patent_doc_number] => 20190359575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/228448
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228448 | DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF | Dec 19, 2018 | Abandoned |
Array
(
[id] => 15054793
[patent_doc_number] => 10457685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor
[patent_app_type] => utility
[patent_app_number] => 16/228539
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13954
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228539 | [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor | Dec 19, 2018 | Issued |